Skip to main content

UC Davis Health System

Haines Ely, M.D. View profile as PDF

Haines  Ely

Clinical Interests

Dr. Haines Ely M.D has been teaching residents at UC Davis since 1975 (before there was a full time department of dermatology). He is particularly interested in dermatologic therapy and has lectured on the most recent advances in therapy all over this country as well as in Europe and Australia. In 1996 he spoke on "What's new in dermatologic therapy" at the American Academy of Dermatology annual meeting in Washington D.C. His topic was "Tumor necrosis factor inhibition in dermatologic disease." This was years before our current biological tnf inhibitors were discovered. He loves to see the most difficult cases with our residents and often comes up with novel therapies for untreatable conditions. He also has a special interest in teledermatology applications here at UC Davis and sees patients in the telemedicine department one day a week.

Title:

Associate Physician

Specialty:

Department:

Dermatology

Division:

Dermatology

Clinic:

Dermatology Clinic

Address/Phone:

Cannery Building
Dermatology
3301 C St., Suite 1300-1400
Sacramento, CA 95816
Driving Directions
Phone: 916-734-6111

Additional Phone:

Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Education:

M.D., University of Southern California, Los Angeles, California, 1971
A.B., Stanford University, Stanford, California, 1967

Internships:

University of Southern California/Los Angeles County Medical Center, Los Angeles, California, 1972

Residency:

University of Southern California/Los Angeles County Medical Center, Los Angeles, California, 1975

Board Certifications:

American Board of Dermatology , 1976
American Board of Pathology, Dermatopathology, 1980

Select Recent Publications:

Ely, H, Pascucci, A, Merkel Cell Carcinoma; Treatment with Bleomycin, 2008, Dermatology Online Journal, in press

Rigel, D, Torres, AM, Ely, H, Imiquimod 5% Cream Following Curettage without Electrodessication for Basal Cell Carcinoma: Three Year Follow Up, 2008, in press

Rigel,D, Torres, AM, Ely, H, Imiquimod 5% Cream Following Curettage Without Electrodesiccation for Basal Cell Carcinoma: Preliminary Report, J Drugs Dermatol. 2008;7(1) Supplement; s15-s16

Rigel, D, Ely, H, Torres, A, et al., Effectiveness of Curettage and Imiquimod 5% Cream in the Treatment of Basal Cell Carcinoma; Clinical and Cosmetic Evaluation, Poster Presentation, American Academy of Dermatology Annual Meeting, San Francisco, 2006

Ely, H., The Bowel Bypass Syndrome, in Clinical Dermatology, Demis, JD, Dobson, RL, Mcguire, J, Thiers, B., eds., Lippincott-Raven, Philadelphia, 1998

Ely, H. Human Phenotypes. The Atopic and Seborrheic: Part II, Cutis, 1997: 59(1): 13-18

Ely, H. Human Phenotypes. The Atopic and Seborrheic: Part III, Cutis, 1997:59(2): 67-70

Ely, H., Dermatologists Deserve a Break, California Physician,1996;13(4):12

Ely, H., Human Phenotypes: The atopic and seborrheic: Part I, Cutis, 1996: 58(1) 27-31.

Ely, H., What’s new in telemedicine, California Physician, 1996; 13(10):45

Ely, H., Physicians on the Internet, California Physician, 1995: 12(10) 35-40.

Ely, H., The Hubris of Some Gatekeepers, (Editorial) California Physician, 1995: 12(3): 17.

Ely, H., Drug Eruption Reference Manual, (Book Review), J Amer Acad Dermatol 1995; 33: 146

Ely, H., Herbs Useful in Dermatologic Therapy (Book Review), J. Amer. Acad. Dermatol 1994; 31: 520

Ely, H., Is Pentoxifylline the Drug of the Decade? (Editorial) J. Amer. Acad. Dermatol. 1994:30(4):639-42.

Ely, H., Recent Developments in Dermatologic Uses of Cyclosporin and Amelioration of Renal Toxicity with Pentoxifylline, (Review), Current Opinion in Dermatology, 1993:223-230.

Ely, H., Surgical Elyisms, Clinics in Dermatology, 1992: 10: 381-85.

Ely, H., Shocking Therapy: Uses of Transcutaneous Electric Nerve Stimulation in Dermatology, Dermatologic Clinics, 1991:9(1):189-97.

Ely, H., Therapies You’ve Probably Never Heard Of, Dermatologic Clinics, 1989: 7(1): 19-35.

Ely, H., White Blood Cells as Mediators of Hyperviscosity-Induced Tissue Damage in Neutrophilic Vascular Reactions: Therapy with Pentoxifylline, J. AM. Acad. Dermatol., 1989: 20(4): 677-680.

Ely, P.H., and Thiers, B., eds, Dermatologic Therapy, (2 Volumes) Dermatologic Clinics, W.B. Saunders Co., Philadelphia, 1988 Vol 6(4), 1989 Vol 7(1).

Ely, P.H. and Bard, J.W., Therapy of Livedo Vasculitis with Pentoxifylline, Cutis, 1988: 42: 448-453.

Ely, P.H., Localized Hyperviscosity Syndromes, Hoechst Pharma, 1988:15:54.

Ely, P.H., Pentoxifylline Therapy in Dermatology: A Review of Localized Hyperviscosity and Its Effects on the Skin, Dermatologic Clinics, 1988: 6(4): 585-608.

Ely, H., Chronic Urticaria: Treatment with H2 Receptor Antagonists, JAMA, 1988:259:2467.

Ely, P.H., Pathogenesis of the Bowel Bypass Syndrome (Review), in Pathogenesis of Skin Disease, Dobson, R.L., and Thiers, B. eds, Churchill Livingston, N.Y., 1986. pp 281-305.

Ely, P.H., The Bowel Bypass Syndrome, in Clinical Dermatology, Demis, J.D., Dobson, R.L., McGuire, J., Thiers, B., eds. , Harper and Rowe, Philadelphia, 1984.

Ely, P.H., "Clinical Research", in Controversies in Dermatology, E. Epstein, ed., W.B. Saunders Co., Philadelphia, 1984:453-57.

Ely, P.H., Immunopathology of the Bowel Bypass Syndrome, in Immunodermatology, D.M. MacDonald, ed., Butterworth and Co., London, 1984. 287-89.

Ely, P.H., Vermillionectomy, J Derm. Surg. and Oncol. 1984: 10(3):167.

Ely, P.H., Eczema: A Dialogue, Am. J. Derm. Path., 1983:5(5)413.

Ely. H., "New England Society of Allergy Proceedings National Symposium on Aspirin and Endogenous Mediators of Disease" (Book Review) J. Am. Acad. Dermatol.,1982: 6:282-83.

Ely, P.H., Treatment of Skin Carcinoma of the Face and Neck, JAMA: 1982:247(6):754.

Ely, P.H., and Utsinger, P. Clinical Observations and Immunologic Abnormalities Following Bowel Bypass Surgery, J. Amer. Acad. Dermatol., 1980: 2: 529-30.

Ely, P.H., The Bowel Bypass Syndrome: A Response to Bacterial Peptidoglycans, J. Amer. Acad. Dermatol., 1980:2:473-87.

Ely, P.H., Skin Lesions and Arthritis Associated with Ileojejunal Shunt Surgery: A Possible Peptidoglycan Antigen Disease, Arch. Derm., 1978:114:1831.

Ely, P.H., More on Skin Closures, Arch Derm, 1978:114:125.

Ely, P.H., Balance Beam Alopecia, Arch Derm. 1978:114:968

Utsinger,P., Farber,N., Shapiro, R., Ely, P.H., McLaughlin, G.E., Weisner, K.B., Clinical and Immunologic Study of the Post-Intestinal Bypass Arthritis-Dermatitis Syndrome, Arth. Rhuem., 1978:12:599.

Ely, P.H., Rasheed, S., Rongey, R., Cytopathic Effects Produced by Non-Replicating Human Wart Virus in Vitro, Clin Research, 1975:23:90A.

To see if Haines Ely is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).